Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A₂ (TXA₂) receptor; pharmacological and kinetic studies in vitro

By Maayani Saul   Schwarz Todd E.   Patel Nayana D.   Craddock-Royal Barbara D.   Tagliente Thomas M.  

Platelets, Vol. 14, Iss. 6, 2003-09 ,pp. : 359-374

Informa Healthcare

Access to resources Recommend Favorite

Activation of TxA₂/PGH₂Receptors and Protein Kinase C Contribute to Coronary Dysfunction in Superoxide Treated Rat Hearts

By Gupte S.A.   Okada T.   Tateyama M.   Ochi R.  

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 6, 2000-06 ,pp. : 937-946

Academic Press

Access to resources Recommend Favorite

A New Thromboxane Receptor Antagonist, Z-335, Ameliorates Experimental Thrombosis without Prolonging the Rat Tail Bleeding Time - possible role of TXA 2 in reocclusion after thrombolysis

By Tanaka T.   Ito S.   Higashino R.   Fukuta Y.   Fukuda Y.   Takei M.   Kurimoto T.   Tamaki H.  

Thrombosis Research, Vol. 91, Iss. 5, 1998-09 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite

Adenosine A_2A-Receptor Antagonism and Pathophysiology of Parkinson’s Disease and Drug-Induced Movement Disorders

By  

European Neurology, Vol. 67, Iss. 1, 2011-11 ,pp. : 4-11

Karger

Access to resources Recommend Favorite

Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism

By  

Current Hypertension Reviews, Vol. 13, Iss. 1, 2017-06 ,pp. : 46-56

Bentham Science Publishers

Access to resources Recommend Favorite